Rheumatoid Arthritis

Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at the ACR 2020 annual meeting, reviewing two previous clinical trials that also looked at this question and offering his perspective. 

Dr. Janet Pope reviews abstract #0804 - Factors That Influence Biological Survival in Rheumatoid Arthritis: Results of a Real-world Cohort from the Netherlands-  presented at the ACR 2020 annual meeting.

Dr. Janet Pope reviews abstract #0799 presented Saturday at the ACR 2020 annual meeting.

Dr. Jeff Curtis discusses abstract #0939, which looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at ACR 2020.

Dr. Jonathan Kay leads a panel of rheumatologists from Dublin, Australia, The Philippines, Boston and Baltimore to talk about several initial abstracts that caught their attention at ACR 2020. Panel participants: Dr. Richard Conway, Dr. David Liew, Dr. Sheila Reyes, Dr. Jeffrey Sparks and Dr. Eric Dein.

Dr. David Liew reviews abstracts #0431 presented at the ACR 2020 annual meeting - and shares the results of the Twitter poll he conducted asking when prescribing HCQ, is an EKG routinely ordered either before or doing.  

Dr. Jack Cush discusses abstract #0481 presented Friday at the ACR 2020 annual meeting. 

OHSU rheumatologist Dr. Kevin Winthrop in Portland looks at two posters -- abstracts #0215 and #0229 presented Friday at ACR 2020.

Dr. Sheila Reyes discusses abstract #0205 presented Friday at the 2020 ACR annual meeting.

Boston-based rheumatologist Dr. Jonathan Kay examines an ACR 2020 study (abstract #0431) looking at whether hydroxychloroquine use has injured patients' hearts.